NEW YORK (GenomeWeb) – Vanderbilt University researchers have developed a targeted proteomics assay that could prove useful in the development of cancer immunotherapies. Described in a study published last week in Molecular & Cellular Proteomics, […]
The properties of the human Y chromosome – namely, male specificity, haploidy and escape from crossing over – make it an unusual component of the genome, and have led to its genetic variation becoming a […]
RATIONALE: non-small cell lung cancer (NSCLC)-associated malignant pleural effusions (MPE) are sometimes the only available specimens for molecular analysis. OBJECTIVES: this study evaluates diagnostic yield of NSCLC-associated MPE, its adequacy for immunohistochemistry (IHC) and the […]
Primary vitreoretinal lymphoma (PVRL) is the most common intraocular lymphoma occurring in the eye. It is a high-grade typically B-cell malignancy, arising in the retina, and is often associated with central nervous system (CNS) disease […]
NEW YORK (GenomeWeb) – United Healthcare has included coverage of fecal DNA testing for colorectal cancer in its latest Coverage Determination Guideline, making it the final big US insurer to cover Exact Sciences’ Cologuard, according […]
NEW YORK (GenomeWeb) – Grail and Cirina, two startups looking to commercialize liquid biopsy tests for early cancer detection, have decided to join forces. Cirina, which was founded by Dennis Lo of the Chinese University […]
Urinary incontinence in women is common, with almost 50% of adult women experiencing leakage at least occasionally. Genetic or heritable factors are known to contribute to half of all cases, but until now studies had […]
NEW YORK (360Dx) – Earlier this month, Winship Cancer Institute of Emory University was designated a comprehensive cancer center by the National Institutes of Health, placing it in the top 1 percent of cancer centers […]
Alloreactive T lymphocytes are the primary mediators of allograft rejection. The size and diversity of the HLA-alloreactive T cell repertoire has thus far precluded the ability to follow these T cells and thereby to understand […]
It is an unprecedented time for the treatment of patients with chronic lymphocytic leukemia (CLL) with the recent approval of several targeted agents for use in frontline, relapsed, refractory, and high-risk disease. Traditionally, frontline management […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes